Please login to the form below

Not currently logged in
Email:
Password:

Lucid strikes £11m investment deal with equity firm LDC

Will use the new funds to underpin its infrastructure as it grows

Lucid Group Lucid has agreed an £11m investment deal with private equity company LDC to support its US expansion and increase its infrastructure.

The medical communications group has been growing rapidly, most recently launching a new strategic consultancy and winning a Queen’s Award for international trade earlier this year.

Its agreement with LDC will see the firm, which is the private equity arm of the UK’s Lloyds Banking Group, take a minority investment in Lucid.

LDC investment directors Christian Bruning and Rob Apollo will join the group’s board, with Tim Trotter - current chairman of PEI Media and chief executive chairman of Ludgate Group - appointed as non-executive chairman as a part of the deal.

Lucid’s founders Dennis O’Brien and Jan Steele will continue to lead the business.

O’Brien said: “We felt the time was right to bring on board a strategic partner, and in LDC we have an experienced investor with a strong track record in the healthcare sector.

“From the outset, they have had a flexible approach to the investment, structuring the deal on terms that worked for us.

“We’re now best placed to maximise the growth potential of Lucid and solidify our position as thought leaders and innovators in the medical education market.”

Lucid, which employs over 100 people, has offices in London, Beaconsfield and New York, and has seen a 30% growth in the past two years.

Christian Bruning, investment director at LDC London, said: “In Dennis, Jan and their management we have an experienced team at the helm of the business and we look forward to working alongside them to support the next phase of growth and expansion to build further on the Lucid brand.

Article by
Gemma Jones

12th June 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

What does the future hold for clinical trial recruitment?
The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...